Meticulous Research®—a leading global market research company published a research report titled “Platelet Rich Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes)—Forecast to 2028”.
In the most recent report by Meticulous Research®, the global market for platelet-rich plasma therapy (PRP) is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 12.2% over the forecast period, reaching a value of $882.5 million by 2028. This growth is primarily driven by several factors, including the numerous advantages associated with PRP treatment, heightened awareness regarding PRP therapies, an uptick in musculoskeletal, sports, and orthopedic injuries, as well as the escalating number of cosmetic procedures worldwide.
Furthermore, the expanding utilization of PRP treatments and advancements in healthcare within emerging economies are poised to present substantial growth prospects for providers of platelet-rich plasma therapy. However, the availability of alternatives to PRP treatment and potential side effects linked with such treatments are anticipated to moderately hinder market growth during the forecast period. Additionally, stringent regulatory frameworks concerning PRP use pose a significant challenge within this market.
This global study on the platelet-rich plasma market offers historical market data for 2019 and 2020, estimated current data for 2021, and forecasts for 2028. The market is segmented by Type (Pure Platelet-rich Plasma, Leukocyte-rich PRP, Platelet-rich Fibrin, and Leukocyte & Platelet-rich Fibrin), Application (Orthopedics & Traumatology, Dermatology & Cosmetology, Rheumatology, Stomatology & Odontology, Ophthalmology, Others), End User (Hospitals & Clinics, Research Institutes), and Geography. The report also assesses industry competitors and their market share globally and regionally.
In terms of type, the global platelet-rich plasma therapy market is categorized into pure PRP, leukocyte–rich PRP, pure platelet-rich fibrin, and leukocyte & platelet-rich fibrin. In 2021, the pure PRP segment is projected to dominate the global market, driven by its minimal risks and its effectiveness in accelerating tissue, tendon, and bone healing processes.
Regarding application, the market is segmented into orthopedics & traumatology, rheumatology, dermatology and cosmetology, ophthalmology, stomatology and odontology, and other applications. The orthopedics and traumatology segment is expected to hold the largest market share in 2021 due to the high incidence of musculoskeletal injuries, such as fractures, which fuels the demand for PRP treatments.
In terms of end users, hospitals and clinics are expected to occupy a larger share of the global platelet-rich plasma market in 2021, attributed to increased healthcare spending, rising awareness, and prescriptions for PRP treatments across various medical conditions.
Download Free Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5218
wGeographically, this research report provides a thorough analysis of major regions, including North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America (Brazil, Argentina, Mexico, and RoLATAM), and the Middle East & Africa.
Key players in the global platelet-rich plasma therapy market include Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.).
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research